Publications
A comprehensive collection of peer-reviewed research, book chapters, and academic contributions spanning five decades.
Filter Publications
Search and filter by category, year, or keywords
J. Cervical ripening with self administered iso sorbide mononitrate vaginally, in uncomplicated singleton pregnancies at 39 weeks gestation: a double blind randomised controlled trial
Authors: K Attanayake, M Goonewardene
Introduction Vaginal iso sorbide mononitrate (ISMN) is effective in pre induction cervical ripening in post dated pregnancies. Objectives To determine the effectiveness and accept- ability of ISMN self-administered vaginally at home, in causing cervical ripening in uncomplicated singleton pregnancies at 39 weeks gestation. Methods Consecutive women with uncomplicated singleton pregnancies, presenting between 01 October 2013 and 31 March 2014, with a modified Bishop score (MBS) of $<5$ at a gestational age (GA) of 273 days to the University Obstetric Unit of Teaching Hospital Maha- modera Galle, were allocated by stratified (primip/multip) block randomisation to self-administer vaginally at home every other day, five doses of 60 mg of sustained release form of ISMN (ISMN-SR); $(n=72$ cases), or pyridoxine 10 mgs ( $(n=72$, controls), from GA 273 to 282 days. Results The mean MBS and the mean change of MBS at 282 days, and the proportions with spontaneous onset of labour (SOL) by GA 282 days, were not significantly different between the two groups. A vast majority were satisfied with outpatient therapy (80% cases vs.76% controls), were happy to use it in a subsequent preg-nancy (89% cases vs. 86% controls) and would recom-mend it to a friend (93% cases vs. 90% controls). Conclusions Home adminstrated vaginal ISMN therapy from GA 39 weeks was not effective in causing significant cervical ripening or promoting SOL, but it was acceptable to women.
J. The agreement between haematological indices obtained by different methods
Authors: Goonewardene IMR, Fernando RJ, Liyanage C, Somasiri KG
K. Is intermittent oral iron supplementation in pregnancy appropriate for South Asian Countries?
Authors: Goonewardene M
K. WHO recommendations for induction of labour: RHL commentary
Authors: Goonewardene M, Rameez MFM, Kaluarachchi A, Perera H
The WHO guidelines on induction of labour are valid and useful and can be implemented in all under- resourced settings. The recommendations are likely to be cost-effective and acceptable to pregnant women, their obstetricians and policy-makers in under-resourced settings.
Knowledge and awareness about gynaecological cancer
Authors: Padumadasa S, Goonewardene M
Knowledge awareness and acceptability of contraceptive methods among pregnant women attending an antenatal clinic
Authors: Kularatna MDCS, Goonewardene M
L. Do all pregnant women need iron?
Authors: Goonewardene M
L. The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial
Authors: R S Vidanagamage, IMR Goonewardene
Objective Nitric oxide donors have been shown to cause cervical ripening. The aim of this study was to evaluate the effects on the mother and the fetus when isosorbide mononitrate (ISMN) 40 mg or the sustained release ISMN (ISMNSR) 60 mg was administered vaginally for pre- induction cervical ripening. Methods A double blind randomised controlled trial. Consecutive women $(n=156)$ with uncomplicated singleton pregnancies between 40 weeks +5 days and 41 weeks' gestation with modified Bishop Scores (MBS) <5 were allocated by stratified (primp / multip) block rando- misation to receive ISMN 40 mg, ISMN-SR 60 mg or the placebo vitamin C 100 mg vaginally. Results At the commencement of the study the parity and mean age, MBS, pulse rate (PR), systolic and diastolic blood pressure (SBP and DBP), umbilical artery resistance index (RI) and pulsatility index (PI) were similar among the three treatment groups. There was significant increase $(p<0.001)$ of mean MBS by 1.3 (95% CI 0.8, 1.7) in primips and by 1.7 (95% CI 1.3, 2.0) in multips at 6 hours and by 2.4 (95% CI 1.9, 2.7) in primips and by 2.3 (95% CI 2.0, 2.6) in multips at 48 hours. Greater proportions of primips (42% with ISMN - SR 60 mg and 31% with ISMN 40 mg, $p<0.05)$ were favourable for induction of labour (IOL) after 48 hours in comparison with the controls (7.6%). Greater proportions of multips (46% with ISMN - SR 60 mg and 40% with ISMN 40 mg, $p<0.05)$ were favourable for IOL after 48 hours in comparison with the controls (16%). A mean increase of PR by 6.7-10.2 bpm (95% CI 5.0 12.5, $p<0.001$ in both ISMN groups at 180 minutes persisted up to 360 minutes. A mean reduction of SBP by 7.310 mmHg (95% $Cl=$ 8.0-11.5, $p<0.001)$ in both ISMN groups at 180 minutes persisted up to 360 mins. No significant change was seen in DBP, RI or Pl. Frequency of maternal side effects (mainly headache) were higher in ISMN groups. Conclusions When compared with the placebo Vitamin C 100 mg, vaginal ISMN 40 mg and ISMN SR 60 mg lead to significantly greater cervical ripening after 6 hours and 48 hours respectively. Therefore vaginal ISMN leads to more women becoming favourable for IOL. Vaginal ISMN does not affect placental blood flow but causes headaches and clinically insignificant maternal haemodynamic changes.
LANKAN MEDICAL GRADUATES
Authors: Malik Goonewardene
Leading Article. Research Synthesis
Authors: Goonewardene Malik
M. Antenatal oral iron supplementation: why & how?
Authors: Goonewardene M.
M. Induction of labour and its outcome in a teaching hospital
Authors: RWMDS Rathnayake, Malik Goonewardene
Introduction: A new guideline and a strict protocol of oxytocin infusion administered via an infusion pump was adopted for induction of labour (IOL) in the University Obstetric Unit, Teaching Hospital, Mahamodara, Galle, in 2006. Objective: To describe IOL and its outcome before and after adopting this new guideline and strict protocol of oxytocin infusion at the University Obstetric Unit, Teaching Hospital, Mahamodara, Galle. Methods: A prospective descriptive study. Using a pretested form data collected from 322 consecutive women who had IOL during a period of nine months commencing 15th June 2006, were compared with those obtained in the Teaching Hospital, Mahamodara, Galle in 2003 before the new guideline and strict protocol was implemented in the University Obstetric Unit, Galle. Results: In the University Obstetric Unit the rate of IOL was 8.5% in 2006. The leading indications for IOL were past dates (45.8% in 2003 and 45% in 2006) and pre labour rupture of membranes (28.2% in 2003 and 35.4% in 2006). Successful vaginal deliveries showed a possible increase from 84.7% in 2003 to 90.4% in 2006 and failed inductions showed a possible reduction from 3.8% in 2003 to 2.2% in 2006 $(p=0.09)$. The mean induction delivery interval for a successful vaginal delivery was significantly shorter (318 min 95% CI 307 327, $p<0.04)$ in 2006 compared to that of 2003 (343 min 95% CI 333-370). The mean dose of oxytocin used for a successful vaginal delivery showed a possible increase from 6.7 units (95% CI 5.8-7.4, $p=0.11)$ in 2003 to 10.4 units (95% CI 6.7-16.2) in 2006. Mean duration prior to a diagnosis of a failed induction markedly decreased from 932 min (95% CI 790-1073) in 2003 to 699 min (95% CI 590809, $p=0.005)$ in 2006. Mean number of oxytocin units prior to a diagnosis of a failed induction markedly increased from 15 units (95% $CI=15$) in 2003 to 25.8 units (95% CI 21-30, $p<0.001)$ in 2006. Caesarean sections after IOL showed a possible reduction from 15.3% in 2003 to 9.6% in 2006 $(p=0.09)$ There was no significant change in neonatal outcome from 2003 to 2006. Conclusion: After the adoption of the new guideline and oxytocin infusion protocol in 2006, IOL and its outcome have improved in the University Obstetric Unit, Galle.